Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Natalia Vieira de Souza"'
Autor:
Michele Georges Issa, Natalia Vieira de Souza, Bruna Wenyi Chuang Jou, Marcelo Dutra Duque, Humberto Gomes Ferraz
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 892 (2022)
The development of extended-release dosage forms with adequate drug release is a challenge for pharmaceutical companies, mainly when the drug presents high solubility, as in Biopharmaceutics Classification System (BCS) class I. This study aimed to de
Externí odkaz:
https://doaj.org/article/45f897d9aac24cf0910014c15f3e6849
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 53, Iss 4 (2018)
ABSTRACT The search for new pharmaceutical dosage forms and different drug delivery systems already used in therapeutics is a global trend, serving as an opportunity to expand the portfolio for the pharmaceutical industry. In this context, multiparti
Externí odkaz:
https://doaj.org/article/f65907b4595d4708a4756f597aeb9e86
Autor:
Natalia Vieira de Souza
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
Este trabalho teve por finalidade desenvolver um método para a caracterização do perfil de dissolução de suspensões de mebendazol (MBZ), discriminatório para as formas polimórficas do fármaco. Pertencendo a classe II do Sistema de Classifica
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 53, Iss 4 (2018)
Brazilian Journal of Pharmaceutical Sciences, Volume: 53, Issue: 4, Article number: e00216, Published: 07 MAY 2018
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Volume: 53, Issue: 4, Article number: e00216, Published: 07 MAY 2018
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
The search for new pharmaceutical dosage forms and different drug delivery systems already used in therapeutics is a global trend, serving as an opportunity to expand the portfolio for the pharmaceutical industry. In this context, multiparticulate sy